AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30745118
Drug: Chemotherapy or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy or next-generation hormone therapies
Trial: 23392919
Drug: On and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On and off medication states (for VIDEO group)
Trial: 22134562
Drug: CLNP 1.2%-BPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLNP 1.2%-BPO 3% gel
Trial: 22134562
Drug: CLNP 1.2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLNP 1.2% gel
Trial: 22134562
Drug: BPO 3%
RxNorm normalized name: BPO 3% Foaming Cloth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPO 3% gel
Trial: 19549737
Drug: NaCl supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl supplementation (100 mmol/day) during telmisartan treatment with or without HCT
Trial: 19549737
Drug: Placebo during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo during telmisartan treatment with or without HCT
Trial: 15085888
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day of docosahexaenoic acid (DHA) supplementation
Trial: 15887725
Drug: Topical itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical itraconazole (1%)
Trial: 15887725
Drug: Topical and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical and systemic itraconazole
Trial: 9088580
Drug: Transdermal nicotine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine, 15 mg/day
Trial: 9088580
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray, 24-1 mg doses/day
Trial: 9088580
Drug: Placebo nicotine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nicotine nasal spray, 24 doses/day
Trial: 7680306
Drug: Chemotherapy (COPP/ABVD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (COPP/ABVD scheme, with or without mediastinal irradiation)
Trial: 3749604
Drug: Aceglutamide aluminum
RxNorm normalized name: aceglutamide aluminum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aceglutamide aluminum (N‐acetyl‐L‐glutamine aluminum complex) administered in multiple daily doses (total of 3290 mg over 14 days)
Trial: 26862079
Drug: Information about
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information about treatment for alcohol abuse
Trial: 26862079
Drug: Information about
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information about treatment for alcohol dependence
Trial: 20356492
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human tissue-type plasminogen activator (rt-PA) 50 mg
Trial: 20356492
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human tissue-type plasminogen activator (rt-PA) 100 mg
Trial: 15997603
Drug: Equivalent hours
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equivalent hours of treatment in the same intensive behavioral rehabilitation program
Trial: 12764404
Drug: Antihypertensive drugs
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drugs (group DT; 100 patients)
Trial: 12764404
Drug: ACE-I/ARB treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-I/ARB treatment in DT group
Trial: 10334417
Drug: Prestudy medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prestudy medication with calcium antagonists.
Trial: 1758253
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) analgesia
Trial: 25891440
Drug: Vilazodone 20
RxNorm normalized name: vilazodone 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilazodone 20 mg/day
Trial: 22106941
Drug: Vilazodone 40
RxNorm normalized name: vilazodone 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilazodone 40 mg/day
Trial: 30044247
Drug: Vilazodone (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilazodone (combined 20 and 40 mg/day)
Trial: 19694628
Drug: venlafaxine-quetiapine (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: venlafaxine-quetiapine (375 mg/day, 600 mg/day)
Trial: 19694628
Drug: imipramine (plasma-levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: imipramine (plasma-levels 200-300 microg/l)
Trial: 17907276
Drug: Antidementia drug
RxNorm normalized name: metoclopramide
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antidementia drug treatment
Trial: 12975222
Drug: Cholinesterase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitors (ChEIs)
Trial: 12237200
Drug: Opioid blockade
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid blockade (8 mg naloxone i.v.)
Trial: 10971304
Drug: Pseudoephedrine (PSE)
DrugBank: Pseudoephedrine (DB00852)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine (PSE) 180 mg
Trial: 1569238
Drug: Betaxolol 5
RxNorm normalized name: betaxolol 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 5 mg once daily
Trial: 1569238
Drug: Betaxolol 10
RxNorm normalized name: betaxolol 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 10 mg once daily
Trial: 1569238
Drug: Betaxolol 20
RxNorm normalized name: betaxolol 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 20 mg once daily
Trial: 2997314
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran diet (normal daily intake + 78 gm wheat bran per day)
Trial: 2997314
Drug: Cellulose diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellulose diet (normal daily intake + 30 gm cellulose per day)
Trial: 2997314
Drug: Baseline diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline diet (normal daily intake)
Trial: 30203747
Drug: Intravenous nutrition
RxNorm normalized name: Intravenous nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nutrition therapy for observation group infants
Trial: 19844199
Drug: Half doses
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half doses of PEG-ES and 12 tablets of 12 mg senna (HDG)
Trial: 19844199
Drug: High-dose senna
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose senna (SG)
Trial: 16227727
Drug: Other medications
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other medications for ocular complications or pain relief
Trial: 3886998
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific therapy
Trial: 2190464
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (IS-5-MN), 20 mg
Trial: 688734
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg N acetate and 50 μg EE2 (Minovlar)
Trial: 688734
Drug: 1.05 mg
RxNorm normalized name: thiamine 1.05 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.05 mg N (Noriday)
Trial: 688734
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg N acetate and 50 μg EE2 (Gynovlar)
Trial: 688734
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg N with 50 μg EE2 (intravenous preparation)
Trial: 25418575
Drug: Internet-based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based Cognitive Behaviour Therapy (ICBT)
Trial: 21377690
Drug: Usual pharmacotherapy
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual pharmacotherapy plus aerobic exercise (N = 22)
Trial: 21377690
Drug: Usual pharmacotherapy
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual pharmacotherapy (N = 11)
Trial: 16995333
Drug: Almotriptan 12.5
RxNorm normalized name: almotriptan 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 12.5 mg with ethanol (target plasma concentration 0.8 g/kg)
Trial: 16995333
Drug: Almotriptan 12.5
RxNorm normalized name: almotriptan 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 12.5 mg alone
Trial: 12891200
Drug: Enoxaparin, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin, 100 IU/kg twice daily (n = 220)
Trial: 12891200
Drug: Tinzaparin, 175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinzaparin, 175 IU/kg once daily (n = 218)
Trial: 6624694
Drug: L-carnitine oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine oral treatment (2 g/day)
Trial: 30803131
Drug: DFM30 (tinted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DFM30 (tinted daily SPF‐30 facial moisturizer)
Trial: 21544087
Drug: 320 mg
RxNorm normalized name: aspirin 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 320 mg anthocyanins twice daily
Trial: 18629569
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of calcium plus 800 IU of vitamin D
Trial: 18629569
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of calcium
Trial: 17244291
Drug: Cash and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cash and Counseling consumers (treatment group)
Trial: 2695287
Drug: 50 ug
RxNorm normalized name: DIGOXIN 250 ug ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 ug ethinyl estradiol (EE) and 1.0 mg norethindrone (NE)
Trial: 2695287
Drug: 35 ug
RxNorm normalized name: ETHYNODIOL DIACETATE 1 mg / ETHINYL ESTRADIOL 35 ug ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 ug ethinyl estradiol (EE) and 1.0 mg norethindrone (NE)
Trial: 2695287
Drug: 35 ug
RxNorm normalized name: ETHYNODIOL DIACETATE 1 mg / ETHINYL ESTRADIOL 35 ug ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 ug ethinyl estradiol (EE) and 0.5 mg norethindrone (NE)
Trial: 324773
Drug: Flurbiprofen (150‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (150‐200 mg daily)
Trial: 329422
Drug: Indomethacin (75‐100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (75‐100 mg daily)
Trial: 27869488
Drug: co-phenylcaine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co-phenylcaine nasal spray
Trial: 27869488
Drug: placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo nasal spray
Trial: 23348881
Drug: Shorter dialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter dialysis treatment times
Trial: 19213681
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy with zoledronic acid (4 mg IV every 6 months for 3 years)
Trial: 17159195
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy without zoledronic acid
Trial: 19213681
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg orally daily)
Trial: 19213681
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg orally daily)
Trial: 19213681
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy with zoledronic acid
Trial: 12843161
Drug: Testosterone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (200 mg mixed esters)
Trial: 17223994
Drug: Nandrolone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nandrolone (200 mg nandrolone decanoate)
Trial: 17223994
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 ml arachis oil vehicle)
Trial: 1835830
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride solution
Trial: 8201953
Drug: Intraperitoneal (IP)
RxNorm normalized name: Intraperitoneal Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal (IP) insulin delivery
Trial: 2740091
Drug: 5% acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% acyclovir in modified aqueous cream (ACV-MAC)
Trial: 2740091
Drug: Modified aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified aqueous cream vehicle (control)
Trial: 129002
Drug: Propranolol (80-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80-160 mg/day)
Trial: 30230409
Drug: Agilepristone (AGL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agilepristone (AGL) 10 mg/kg SC q24h for two consecutive days
Trial: 30230409
Drug: Agilepristone (AGL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agilepristone (AGL) + Misoprostol (MIS) 200 µg/cat PO q12h until abortion
Trial: 30230409
Drug: Misoprostol (MIS)
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol (MIS) 200 µg/cat PO q12h until abortion
Trial: 30230409
Drug: Misoprostol (MIS)
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol (MIS) 400 µg/cat PO q12h until abortion
Trial: 19327412
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (no revascularization)
Trial: 16048810
Drug: External Qi-therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External Qi-therapy (QT)
Trial: 16173532
Drug: Placebo control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo control therapy
Trial: 12528607
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (200 micrograms daily)
Trial: 9483167
Drug: Cabergoline (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (0.25 to 4 mg once daily)
Trial: 9483167
Drug: Levodopa (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa (100 to 600 mg/day)
Trial: 2229496
Drug: Lidocaine/prilocaine (EMLA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine/prilocaine (EMLA) cream (n = 58)
Trial: 2229496
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (n = 25)
Trial: 11413274
Drug: Gabapentin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (1200 mg daily)
Trial: 11413274
Drug: Vigabatrin (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vigabatrin (2000 mg daily)
Trial: 29572094
Drug: ARC-AAT (4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARC-AAT (4.0 mg/kg)
Trial: 26998949
Drug: Individual Nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual Nutrition Therapy and Exercise Regime (alternate weekly visits from a physical therapist and dietitian)
Trial: 26998949
Drug: Individual Nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual Nutrition Therapy and Exercise Regime
Trial: 22251436
Drug: Maraviroc 300
RxNorm normalized name: maraviroc 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maraviroc 300 mg BID for 12 weeks
Trial: 15727644
Drug: Q-switched Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Q-switched Nd:YAG laser (three treatment sessions)
Trial: 19105432
Drug: Calcitonin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitonin (50 units, intramuscular, 2 times each week), Caltrate D (1 tablet, orally, once daily), Alfacalcidol Soft Capsules (0.5 units, orally, once daily)
Trial: 16497637
Drug: Individualized nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized nutrition and lifestyle counselling (at least twice a year)
Trial: 14502777
Drug: Breast conservation
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast conservation therapy (BCT)
Trial: 10321561
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with a standardized Dermatophagoides pteronyssinus (DP)‐D. farinae (DF) 50/50 extract, cumulative dose of about 104000 IR over 24 months.
Trial: 1658863
Drug: Glycerol treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol treatment
Trial: 1658863
Drug: No anti-edema
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anti-edema treatment
Trial: 21625426
Drug: G-CSF (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (10 µg/kg body weight/day for 10 days)
Trial: 3064972
Drug: Controlled-release diazepam
RxNorm normalized name: diazepam Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release diazepam (10 mg once daily)
Trial: 3064972
Drug: Conventional diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional diazepam (5 mg 3-times daily)
Trial: 29891606
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g every day (QD) for 7 doses
Trial: 29891606
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g every other day (QOD) for 3 doses
Trial: 26936043
Drug: New drug
RxNorm normalized name: varicella zoster immune globulin (Investigational New Drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drug trials
Trial: 23733372
Drug: Pasireotide 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 600 μg
Trial: 23733372
Drug: Pasireotide 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 900 μg
Trial: 23733372
Drug: Pasireotide 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 1200 μg
Trial: 16603776
Drug: plain lubricant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: plain lubricant gel
Trial: 9702620
Drug: Nicardipine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 5 mg i.v. rapid infusion
Trial: 9702620
Drug: Nicardipine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 10 to 15 mg i.v. rapid infusion
Trial: 9702620
Drug: Nicardipine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 1.25 to 5 mg i.v. bolus
Trial: 9702620
Drug: Nicardipine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 5 mg i.v. bolus
Trial: 9702620
Drug: Nicardipine 2.5
RxNorm normalized name: niCARdipine 2.5 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 2.5 to 5 mg i.v. bolus with labetalol 10 mg i.v.
Trial: 9702620
Drug: Nicardipine 2.5
RxNorm normalized name: niCARdipine 2.5 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 2.5 mg i.v. bolus with labetalol 10 mg i.v.
Trial: 2239218
Drug: Amoxicillin/clavulanate for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate for 4 weeks
Trial: 7045314
Drug: Oral high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral high-dose prednisone therapy (2 mg/kg/day)
Trial: 7045314
Drug: Pulse methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulse methylprednisolone therapy (30 mg/kg/day, not to exceed 1 gm/day) followed by prednisone (2 mg/kg/day)
Trial: 24890542
Drug: Prasugrel 60-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60-mg loading dose (n = 25)
Trial: 24890542
Drug: Ticagrelor 360-mg
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 360-mg loading dose (n = 25)
Trial: 22865589
Drug: Preoperative topical
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative topical antimicrobial decolonization with a 5-day regimen of chlorhexidine skin rinses and intranasal mupirocin coupled with standard perioperative systemic antimicrobial prophylaxis
Trial: 15531906
Drug: Pegfilgrastim (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegfilgrastim (12 mg single dose)
Trial: 15531906
Drug: Unconjugated G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unconjugated G-CSF (8.5 mug/kg/day)
Trial: 15531906
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions post high-dose melphalan (200 mg/m2) and autografting
Trial: 15013248
Drug: bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupropion SR 300 mg/day
Trial: 10990148
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone therapy (6.7 microg/kg/day for 12 weeks)